Year archive

CLEO DIAGNOSTICS LTD — 2024 filings

All 26 regulatory filings released by CLEO DIAGNOSTICS LTD (COV) in 2024, sourced directly from the official regulator.

26 Filings

2024 Period

2024 filings (26)

Filing	Released	Lang
CLEO Further Expands Ovarian Cancer Trial with Siles Health 2 pages 2.8MB Regulatory Filings	2024-12-09	English
The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial 3 pages 2.9MB Regulatory Filings	2024-11-26	English
Results of Annual General Meeting 2 pages 378.6KB Regulatory Filings	2024-11-26	English
Quarterly activities and cashflow report 9 pages 837.0KB Regulatory Filings	2024-10-15	English
Notice of Annual General Meeting/Proxy Form 21 pages 779.8KB Regulatory Filings	2024-10-03	English
Letter to Shareholders 1 page 2.0MB Regulatory Filings	2024-10-03	English
Notice Required Under ASX Listing Rule 3.13.1 1 pag Regulatory Filings	2024-09-22	English
Cleo Commences U.S. Clinical Trials 2 pages 534.1KB Regulatory Filings	2024-09-05	English
ASX Listing Rule 4.10.19 1 page 361.6KB Regulatory Filings	2024-08-27	English
Appendix 4E and 2024 Annual Report 50 pages 7.5MB Regulatory Filings	2024-08-26	English
Appendix 4G and Corporate Governance Statement 34 pages 626.7KB Regulatory Filings	2024-08-26	English
Change of Registry Address 1 page 369.9KB Regulatory Filings	2024-08-06	English
CLEO Selects U.S. Clinical Trial Sites 2 pages 2.9MB Regulatory Filings	2024-07-30	English
Quarterly activities and cashflow report 10 pages 850.1KB Regulatory Filings	2024-07-23	English
Cleo Commences US Regulatory Process with FDA 2 pages 2.9MB Regulatory Filings	2024-06-25	English
Application for quotation of securities - COV 5 pages 16.6KB Regulatory Filings	2024-06-23	English
Restricted securities to be released from escrow 1 Regulatory Filings	2024-06-13	English
COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark 3 pages 2.9MB Regulatory Filings	2024-05-28	English
Quarterly activities and cashflow report 12 pages 4.6MB Regulatory Filings	2024-04-28	English
COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials 3 pages 2.9MB Regulatory Filings	2024-04-10	English
CLEO Appoints Partner to Commence U.S. Market Access Program 3 pages 2.9MB Regulatory Filings	2024-04-01	English
Peer-Review Supports CLEOs Ovarian Cancer Detection Tech 3 pages 2.9MB Regulatory Filings	2024-03-24	English
Appendix 4D and Half Yearly Accounts 23 pages 787.4KB Regulatory Filings	2024-02-28	English
Corporate Presentation February 2024 21 pages 2.5MB Regulatory Filings	2024-02-19	English
Cleo Completes Design Transfer 2 pages 2.8MB Regulatory Filings	2024-02-11	English
Quarterly activities and cashflow report 9 pages 1.1MB Regulatory Filings	2024-01-30	English